Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
Marina N NikiforovaStephanie MercurioAbigail I WaldMichelle Barbi de MouraKeith CallenbergLucas Santana-SantosWilliam E GoodingLinwah YipRobert L FerrisYuri E NikiforovPublished in: Cancer (2018)
The ThyroSeq v3 GC analyzes 5 different classes of molecular alterations and provides high accuracy for detecting all common types of thyroid cancer and parathyroid lesions. The analytical sensitivity, specificity, and robustness of the test have been successfully validated and indicate its suitability for clinical use. Cancer 2018;124:1682-90. © 2018 American Cancer Society.